ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 38 filers reported holding ETON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $156,404 | +36.0% | 37,507 | +13.9% | 0.00% | – |
Q2 2023 | $114,971 | -9.8% | 32,943 | -0.4% | 0.00% | – |
Q1 2023 | $127,397 | +48.8% | 33,090 | +9.0% | 0.00% | – |
Q4 2022 | $85,601 | +33.8% | 30,355 | 0.0% | 0.00% | – |
Q3 2022 | $64,000 | -20.0% | 30,355 | 0.0% | 0.00% | – |
Q2 2022 | $80,000 | -39.4% | 30,355 | 0.0% | 0.00% | – |
Q1 2022 | $132,000 | +1.5% | 30,355 | 0.0% | 0.00% | – |
Q4 2021 | $130,000 | -15.0% | 30,355 | 0.0% | 0.00% | – |
Q3 2021 | $153,000 | -18.2% | 30,355 | 0.0% | 0.00% | – |
Q2 2021 | $187,000 | -85.6% | 30,355 | -82.9% | 0.00% | – |
Q1 2021 | $1,302,000 | -12.8% | 177,958 | -3.1% | 0.00% | – |
Q4 2020 | $1,493,000 | +14.0% | 183,626 | +10.8% | 0.00% | – |
Q3 2020 | $1,310,000 | +333.8% | 165,678 | +198.8% | 0.00% | – |
Q2 2020 | $302,000 | +243.2% | 55,440 | +159.2% | 0.00% | – |
Q1 2020 | $88,000 | -42.9% | 21,393 | 0.0% | 0.00% | – |
Q4 2019 | $154,000 | +14.1% | 21,393 | 0.0% | 0.00% | – |
Q3 2019 | $135,000 | – | 21,393 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |